DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Revenue

DAE HWA Pharmaceutical had revenue of 35.96B KRW in the quarter ending June 30, 2025, a decrease of -7.32%. This brings the company's revenue in the last twelve months to 148.54B, up 0.82% year-over-year. In the year 2024, DAE HWA Pharmaceutical had annual revenue of 149.41B with 5.69% growth.

• Revenue (ttm): 148.54B
• Revenue Growth: +0.82%
• P/S Ratio: 1.75
• Revenue / Employee: 482.29M
• Employees: 308
• Market Cap: 259.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	149.41B	8.05B	5.69%
Dec 31, 2023	141.36B	9.45B	7.16%
Dec 31, 2022	131.91B	14.75B	12.59%
Dec 31, 2021	117.16B	7.81B	7.15%
Dec 31, 2020	109.35B	-5.26B	-4.59%